CYT‑101
Recurrent Glioblastoma Multiforme
Phase 1Active
Key Facts
About Cyteph
Cyteph creates off‑the‑shelf allogeneic CMV‑specific CAR‑T therapies for solid tumours, starting with glioblastoma.
View full company profileTherapeutic Areas
Other Recurrent Glioblastoma Multiforme Drugs
| Drug | Company | Phase |
|---|---|---|
| Berubicin | CNS Pharmaceuticals | Phase 2 |